Adenocarcinoma in Situ

This is an early stage of cancer where the abnormal cells are still confined to the place where they started, like the lining of a gland. It's considered pre-cancerous and hasn't spread yet.

Condition

What people with Adenocarcinoma in Situ report

Every report comes from a Lived member, sent anonymously.

Have you had Conization for Adenocarcinoma in Situ?

NameHow it went

About Adenocarcinoma in Situ

What It Is

Adenocarcinoma in situ (AIS) is an early, noninvasive stage of a glandular cancer. Adenocarcinoma means a cancer that starts in cells that line glands or produce mucus. In situ means "in its original place": the abnormal cells are still confined to the lining where they began and have not grown into the surrounding tissue, blood vessels or lymph channels. That is why AIS is often described as preinvasive. It is not yet the kind of cancer that spreads, but left alone it can become one. The term is used most often for two very different places in the body. Cervical AIS develops in the glandular cells lining the canal of the cervix, the lower part of the uterus. Lung AIS is a small tumor, 3 centimeters or less, that grows only along the thin walls of the lung's air sacs; it used to be grouped under the older name bronchioloalveolar carcinoma. The two share a name and a principle, but they have different causes, are found in different ways and are treated differently, so it matters which one a diagnosis refers to.

Causes & Risk Factors

Cervical AIS is caused by a long-lasting infection with high-risk human papillomavirus (HPV), a very common sexually transmitted virus. Types 16 and 18 cause most cases, and type 18 plays a larger role in glandular changes than in the more familiar squamous precancers. Most HPV infections clear on their own; the risk comes from an infection the immune system does not control. That is why a weakened immune system (from HIV, the human immunodeficiency virus, an organ transplant, or medicines that suppress immunity) and smoking raise the risk. HPV vaccination is expected to prevent many cases and works best when given before any exposure to the virus. Cervical AIS is most often diagnosed in people in their mid-30s. The causes of lung AIS are less clearly defined. Smoking is the most important risk factor for lung cancer overall, and secondhand smoke, radon, some workplace exposures and a family history also contribute. Researchers have not pinned down which of these matter most for AIS specifically, and having a risk factor does not mean it caused an individual's tumor.

How It's Diagnosed

Cervical AIS almost never causes symptoms, so it is usually found through routine cervical screening. Because it starts inside the cervical canal, abnormal glandular cells can be missed by a Pap test alone; adding an HPV test makes screening more sensitive. An abnormal result leads to colposcopy, a magnified exam of the cervix, often with a biopsy and a sample from inside the canal. A biopsy that shows AIS is not the final answer. In roughly 15% of cases, an invasive cancer is found nearby, so guidelines recommend a cone biopsy (conization), which removes a cone-shaped piece of the cervix in one intact piece. The pathologist checks whether the edges of that tissue, called margins, are clear of abnormal cells and whether any invasion is present. This step matters even when a hysterectomy is already planned, because an invasive cancer would call for a different operation. AIS often occurs alongside precancer of the flat surface (squamous) cells of the cervix, so the cone specimen is checked for both kinds of change. Lung AIS usually shows up on a computed tomography (CT) scan, sometimes one done for another reason, as a ground-glass nodule: a hazy spot that does not completely block out the normal lung structures behind it. Imaging and needle biopsies can suggest AIS, but they cannot confirm it. The diagnosis is made only after the whole nodule is removed and examined under a microscope to make sure there is no invasive area. Positron emission tomography (PET) scans, which highlight active tissue, are not reliable for these lesions.

Treatment Options

For cervical AIS, the cone biopsy is both a diagnostic test and the first treatment. For people who have finished having children, removing the uterus and cervix (a simple hysterectomy) is the preferred definitive treatment, because AIS can include small separate patches, called skip lesions, that a cone may miss even when its margins look clear. If margins remain positive after repeat cones, the surgeon may recommend a more extensive operation because the chance of a hidden invasive cancer is higher. For people who want a future pregnancy, keeping the uterus and relying on the cone excision is an accepted choice when the margins are clear and the person can commit to close follow-up. With clear margins, AIS returns in roughly 3 in 100 people, compared with about 19 in 100 when margins are positive. If clear margins cannot be achieved after repeated excisions, fertility-sparing treatment is not recommended. After childbearing is complete, hysterectomy is preferred if HPV tests have been positive; with consistently negative HPV tests, continuing surveillance is also an accepted choice. For lung AIS, treatment is surgical removal of the nodule. Before a diagnosis is confirmed, a small ground-glass spot is often watched with repeat CT scans, sometimes for years, and surgery is considered if it grows or develops a denser, more solid area. Because these tumors are small and sit near the edge of the lung, surgeons often remove only a wedge or segment rather than a whole lobe (one of the lung's main sections, three on the right and two on the left). This smaller operation controls the tumor while preserving more breathing capacity. In a large trial of small ground-glass lung tumors like AIS, nearly everyone was free of relapse five years after limited surgery, and a separate trial of small early lung cancers found limited surgery worked as well as removing a whole lobe while saving a little more lung function. Radiation and chemotherapy are not standard treatments for AIS at either site.

What to Expect

AIS is a diagnosis of a cancer caught before it has invaded, and the outlook after appropriate treatment is very good. The main work is making sure the lesion is fully removed and keeping up with follow-up. After fertility-sparing treatment for cervical AIS, follow-up is closer than routine screening: HPV and Pap co-testing with a sample from inside the cervical canal every 6 months for 3 years, then yearly for at least 2 more years, or until a hysterectomy once childbearing is complete. If results stay normal for 5 years, the interval may be lengthened. Changes to the cervix progress slowly, typically over years, which is what makes this kind of monitoring effective. A hysterectomy does not end testing: after hysterectomy for AIS, guidelines recommend continued follow-up tests of the vagina, generally for at least 25 years after the diagnosis and even beyond age 65, on a schedule set by the care team. For lung AIS that has been completely removed and confirmed, the tumor is expected not to come back: in the research used to define lung AIS, essentially no one whose tumor was completely removed died of it. Some people have more than one ground-glass spot in the lungs, so the care team may recommend periodic CT scans to watch any others.

When to Seek Help

Keep every follow-up test your care team schedules after treatment for cervical AIS, and arrange screening promptly if you have missed it, since AIS rarely causes symptoms. Contact your care team about vaginal bleeding after sex or between periods, or unusual discharge, even if your last test was normal. For lung AIS, ask about follow-up if a CT report mentions a ground-glass nodule and no plan has been made. Lung AIS itself rarely causes symptoms, so new chest symptoms deserve their own review: see a clinician about a cough that does not go away or gets worse, or about coughing up blood.

Questions to Ask Your Doctor

  1. 1.Was the whole lesion examined to rule out invasion?
  2. 2.Were the margins of the removed tissue clear, and what does that mean for my next step?
  3. 3.Given my plans for pregnancy, is fertility-sparing treatment reasonable for me, and what follow-up would it require?
  4. 4.For a lung nodule, would a wedge or segment removal be enough, and how will we watch any other spots?
  5. 5.How often will I need tests after treatment, and for how many years?

Last reviewed • Oct 2026

Educational content, not medical advice.